日期 影响因子
日期:
2020 年 — 2026 年
2020
2021
2022
2023
2024
2025
2026
影响因子:
–

Safety, Pharmacokinetics, and Pharmacodynamics of a First-in-Class ClC-1 Inhibitor to Enhance Muscle Excitability: Phase I Randomized Controlled Trial

首个用于增强肌肉兴奋性的ClC-1抑制剂的安全性、药代动力学和药效学：I期随机对照试验

期刊:Clinical Pharmacology & Therapeutics
影响因子:5.5
doi:10.1002/cpt.3516
Ruijs, Titia Q; de Cuba, Catherine M K E; Heuberger, Jules A A C; Hutchison, John; Bold, Jane; Grønnebæk, Thomas S; Jensen, Klaus G; Chin, Eva; Quiroz, Jorge A; Petersen, Thomas K; Flagstad, Peter; de Kam, Marieke L; van Esdonk, Michiel J; Klaassen, Erica; Doll, Robert J; Koopmans, Ingrid W; de Goede, Annika A; Aulin, Linda B S; Pedersen, Thomas H; Groeneveld, Geert Jan
发表日期：2025
文献求助 收藏

Correction: Clinical Pharmacokinetics of Psilocin After Psilocybin Administration: A Systematic Review and Post‑Hoc Analysis

更正：裸盖菇素给药后裸盖菇素的临床药代动力学：系统评价和事后分析

期刊:Clinical Pharmacokinetics
影响因子:4
doi:10.1007/s40262-025-01487-3
Otto, Marije E; van der Heijden, Katelijne V; Schoones, Jan W; van Esdonk, Michiel J; Borghans, Laura G J M; Jacobs, Gabriel E; van Hasselt, J G Coen
发表日期：2025
文献求助 收藏

Clinical Pharmacokinetics of N,N-Dimethyltryptamine (DMT): A Systematic Review and Post-hoc Analysis

N,N-二甲基色胺 (DMT) 的临床药代动力学：系统评价和事后分析

期刊:Clinical Pharmacokinetics
影响因子:4
doi:10.1007/s40262-024-01450-8
van der Heijden, K V; Otto, M E; Schoones, J W; van Esdonk, M J; Borghans, L G J M; van Hasselt, J G C; van Gerven, J M A; Jacobs, G
发表日期：2025
文献求助 收藏

Clinical Pharmacokinetics of Psilocin After Psilocybin Administration: A Systematic Review and Post-Hoc Analysis

裸盖菇素给药后裸盖菇素的临床药代动力学：系统评价和事后分析

期刊:Clinical Pharmacokinetics
影响因子:4
doi:10.1007/s40262-024-01454-4
Otto, Marije E; van der Heijden, Katelijne V; Schoones, Jan W; van Esdonk, Michiel J; Borghans, Laura G J M; Jacobs, Gabriel E; van Hasselt, J G Coen
发表日期：2025
文献求助 收藏

Item response theory in early phase clinical trials: Utilization of a reference model to analyze the Montgomery-Åsberg Depression Rating Scale

项目反应理论在早期临床试验中的应用：利用参考模型分析蒙哥马利-奥斯伯格抑郁评定量表

期刊:Cpt-Pharmacometrics & Systems Pharmacology
影响因子:3
doi:10.1002/psp4.13018
Otto, Marije E; Bergmann, Kirsten R; de Kam, Marieke L; Recourt, Kasper; Jacobs, Gabriël E; van Esdonk, Michiel J
神经科学
发表日期：2023
文献求助 收藏

Effects of Mexiletine and Lacosamide on Nerve Excitability in Healthy Subjects: A Randomized, Double-Blind, Placebo-Controlled, Crossover Study

美西律和拉考沙胺对健康受试者神经兴奋性的影响：一项随机、双盲、安慰剂对照、交叉研究

期刊:Clinical Pharmacology & Therapeutics
影响因子:5.5
doi:10.1002/cpt.2694
Ruijs, Titia Q; Koopmans, Ingrid W; de Kam, Marieke L; van Esdonk, Michiel J; Koltzenburg, Martin; Groeneveld, Geert Jan; Heuberger, Jules A A C
发表日期：2022
文献求助 收藏

Saliva as a sampling matrix for therapeutic drug monitoring of gentamicin in neonates: A prospective population pharmacokinetic and simulation study

以唾液为采样基质进行新生儿庆大霉素治疗药物监测：一项前瞻性群体药代动力学和模拟研究

期刊:British Journal of Clinical Pharmacology
影响因子:3
doi:10.1111/bcp.15105
Samb, Amadou; Kruizinga, Matthijs; Tallahi, Younes; van Esdonk, Michiel; van Heel, Willemijn; Driessen, Gertjan; Bijleveld, Yuma; Stuurman, Rik; Cohen, Adam; van Kaam, Anton; de Haan, Timo R; Mathôt, Ron
发表日期：2022
文献求助 收藏

Impact of enantiomer-specific changes in pharmacokinetics between infants and adults on the target concentration of racemic ketorolac: A pooled analysis

婴儿和成人之间对映体特异性药代动力学变化对消旋酮咯酸靶浓度的影响：一项汇总分析

期刊:British Journal of Clinical Pharmacology
影响因子:3
doi:10.1111/bcp.14547
Cloesmeijer, Michael E; van Esdonk, Michiel J; Lynn, Anne M; Smits, Anne; Tibboel, Dick; Daali, Youssef; Olkkola, Klaus T; Allegaert, Karel; Mian, Paola
发表日期：2021
文献求助 收藏

Predictive performance of parent-metabolite population pharmacokinetic models of (S)-ketamine in healthy volunteers

(S)-氯胺酮母体-代谢物群体药代动力学模型在健康志愿者中的预测性能

期刊:European Journal of Clinical Pharmacology
影响因子:2.7
doi:10.1007/s00228-021-03104-1
Otto, M E; Bergmann, K R; Jacobs, G; van Esdonk, Michiel J
代谢
发表日期：2021
文献求助 收藏

An exploratory first-in-man study to investigate the pharmacokinetics and safety of liposomal dexamethasone at a 2- and 1-week interval in patients with metastatic castration resistant prostate cancer

一项探索性首次人体研究，旨在研究脂质体地塞米松在转移性去势抵抗性前列腺癌患者中，间隔 2 周和 1 周给药的药代动力学和安全性。

期刊:Pharmacology Research & Perspectives
影响因子:2.3
doi:10.1002/prp2.845
Vrouwe, Josephina P M; Kamerling, Ingrid M C; van Esdonk, Michiel J; Metselaar, Josbert M; Stuurman, Frederik E; van der Pluijm, Gabri; Burggraaf, Jacobus; Osanto, Susanne
前列腺癌
肿瘤
肿瘤免疫
发表日期：2021
文献求助 收藏